Re-Appointment Of Cost Auditor For Financial Year 2026-2027
Filed with BSE · · 2 pages · English
Office: 903-909. 9th Floor, Bigjos Tower, Netaji Subhash Place, Delhi-110034, India Telephone no.: 011-27355742, 71239900(44 Lines), CIN: L74999RJ1992PLC013387 ____________________________________________________________________________________ 30.05.2026 Sub: Outcome of Meeting of the Board of Directors of Titan Biotech Limited (the Company) held on May 30, 2026 1. Approved the Re-appointment of
Earlier from Titan Biotech
- Corporate Action-Board to consider Dividend
- Result_Audited Financial Results For The Quarter And Year Ended March 31, 2026
- Board Meeting Outcome for Outcome Of The Board Meeting Of Titan Biotech Limited Held Today I.E. 30Th May, 2026
- Titan Biotech Limited Press Release May 20 2026
- Board Meeting Intimation for Approval Of The Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Year Ended March 31, 2026 And To Recommend Dividend, If Any, On The Equity Shares Of The Company For The Financial
Later from Titan Biotech
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Titan Biotech Limited Press Release Jun 01 2026
- Closure of Trading Window
- Titan Biotech Limited Press Release Jun 23 2026
- Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech